| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |